Grass Roots Events 2022
View our list of Grass Roots events in 2022 and find an event near you.
Szukaj
Open Innovation at Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Być niezależnym
Kultura korporacyjna Boehringer Ingelheim opiera się na wartościach, które są stosowane od momentu założenia firmy w 1885 roku.
Antibody therapeutics business partnering PetMedix
Combining PetMedix’ expertise in veterinary biotherapeutic technology with Boehringer Ingelheim’s long experience and innovation in human antibody discovery and development provides a unique opportunity for the partners.
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Research Beyond Borders Partnering
Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
Research Beyond Borders overview
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Europe needs a vibrant research eco-system
At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
Boehringer Ingelheim Academy
Find out more about our networking and educational initiative
Kodeks postępowania dostawców
BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements.
Firma Boehringer Ingelheim uzyskała tytuł Top Employer 2023
Firma Boehringer Ingelheim uzyskała tytuł Top Employer 2023
Biotherapeutics Discovery
We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Historia Boehringer Ingelheim w latach 1948-1990,
Historia Boehringer Ingelheim w latach 1948-1990, z kamieniami milowymi
Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE
Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE
Rzadkie, ale nie zapomniane - Co znaczy „rzadkie”?
Rzadkie, ale nie zapomniane
Top Employer 2024
Top Employer 2024
Supply Chain Scholarship for Cowtribe
A supply chain course we sponsored boosted the career of Latifa Saaka
Choroby metaboliczne, nerek i układu krążenia – efekt domina
Choroby metaboliczne, nerek i układu krążenia – efekt domina
Big hearts united to help animals in Ukraine
Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.
Collaboration Driving Innovation
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
Światowy Dzień Chorób Rzadkich 2021
Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia
“Rapid progress towards clinical candidates”
Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
View from Both Sides of the Table
Stawiamy na zarządzanie aliansami